A few years later, the same authors performed work on Panc-1 and T3M4, two other pancreatic cancer lines, and showed that TGF- β, activin, and BMP signaling were inhibited by GPC1, albeit in a very minor manner [89]. This evidence concerns the gene GPC1 and familial pancreatic carcinoma.